Fig. 6From: Real-life impacts of olipudase alfa: The experience of patients and families taking an enzyme replacement therapy for acid sphingomyelinase deficiencyCaregivers’ survey response regarding the degree of need for a new treatment for children with ASMD (n = 10)Back to article page